DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-6.23%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.75B
AUM Growth
+$4.75B
(-7.1%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
40.09%
Holding
155
New
21
Increased
16
Reduced
21
Closed
27
Top Buys
| 1 |
AdaptHealth
AHCO
|
$51.9M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$46.6M |
| 3 |
Xilio Therapeutics
XLO
|
$33.7M |
| 4 |
Viatris
VTRS
|
$26.4M |
| 5 |
Esperion Therapeutics
ESPR
|
$25M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$33.2M |
| 2 |
Molina Healthcare
MOH
|
$30.8M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$28.5M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$25M |
| 5 |
Pacira BioSciences
PCRX
|
$22.3M |
Sector Composition
| 1 | Healthcare | 63.21% |
| 2 | Financials | 1.41% |
| 3 | Consumer Discretionary | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $368M | 7.72% | 19,341,024 | – | – |
|
|
2
Viatris
VTRS
$12.3B
| $281M | 5.9% | 20,774,000 +1,950,000 | +10% | +$26.4M |
|
|
3
AdaptHealth
AHCO
$1.28B
| $250M | 5.25% | 10,225,445 +2,121,653 | +26% | +$51.9M |
|
|
CMAX
4
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $129M | 2.7% | 16,778,750 | – | – |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $117M | 2.46% | 1,377,945 +235,530 | +21% | +$20.1M |
|
|
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $105M | 2.21% | 9,112,019 | – | – |
|
7
Centene
CNC
$14.3B
| $82.7M | 1.73% | 1,003,800 | – | – |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $79.6M | 1.67% | 4,761,138 -102,587 | -2% | -$1.72M |
|
9
Organogenesis Holdings
ORGO
$653M
| $78.1M | 1.64% | 8,456,876 +994,333 | +13% | +$9.19M |
|
10
Pulmonx
LUNG
$69.7M
| $75.9M | 1.59% | 2,366,867 +336,980 | +17% | +$10.8M |
|
|
SILK
11
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $64.6M | 1.36% | 1,517,181 +526,930 | +53% | +$22.5M |
|
12
Larimar Therapeutics
LRMR
$310M
| $62.9M | 1.32% | 5,830,249 | – | – |
|
13
GeneDx Holdings
WGS
$3.72B
| $62.3M | 1.31% | 13,966,824 +118,336 | +0.9% | +$528K |
|
14
Edgewise Therapeutics
EWTX
$1.51B
| $60.1M | 1.26% | 3,933,137 | – | – |
|
|
DCPH
15
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $54.5M | 1.14% | 5,580,456 +4,765,456 | +585% | +$46.6M |
|
|
APR
16
DELISTED
Apria, Inc. Common Stock
APR
| $54M | 1.13% | 1,655,795 +238,095 | +17% | +$7.76M |
|
17
Mirum Pharmaceuticals
MIRM
$3.71B
| $52.4M | 1.1% | 3,282,912 | – | – |
|
18
Glaukos
GKOS
$5.5B
| $51.6M | 1.08% | 1,161,414 +542,414 | +88% | +$24.1M |
|
19
Kura Oncology
KURA
$686M
| $49.2M | 1.03% | 3,513,756 +1,198,339 | +52% | +$16.8M |
|
|
20
Molina Healthcare
MOH
$9.8B
| $42.9M | 0.9% | 134,989 -96,787 | -42% | -$30.8M |
|
21
Alphatec Holdings
ATEC
$2.35B
| $41.1M | 0.86% | 3,594,829 | – | – |
|
22
Protagonist Therapeutics
PTGX
$3.67B
| $40.1M | 0.84% | 1,172,943 -221,057 | -16% | -$7.56M |
|
23
Day One Biopharmaceuticals
DAWN
$769M
| $37.1M | 0.78% | 2,202,533 +491,803 | +29% | +$8.29M |
|
|
24
Cytokinetics
CYTK
$4.23B
| $36.9M | 0.77% | 809,000 -727,758 | -47% | -$33.2M |
|
|
25
Pacira BioSciences
PCRX
$1.2B
| $35.9M | 0.75% | 596,338 -370,898 | -38% | -$22.3M |
|